Myriad Genetics (MYGN) Goodwill & Intangibles (2010 - 2026)

Myriad Genetics (MYGN) has reported Goodwill & Intangibles for 17 consecutive years, with $192.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 64.55% year-over-year to $192.8 million; the TTM figure through Mar 2026 stood at $192.8 million (down 64.55% YoY), while the FY2025 annual figure was $205.0 million, down 62.64% from the prior year.
• Goodwill & Intangibles slipped to $192.8 million in Q1 2026 per MYGN's latest filing, from $205.0 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $666.5 million in Q4 2022 and bottomed at $192.8 million in Q1 2026.
• Historically, Goodwill & Intangibles has averaged $521.7 million across 5 years, with a median of $607.3 million in 2022.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles increased 5.91% — and 2026, when it tumbled 64.55%.
• Myriad Genetics' Goodwill & Intangibles stood at $666.5 million in 2022, then fell by 4.44% to $636.9 million in 2023, then slipped by 13.85% to $548.7 million in 2024, then plunged by 62.64% to $205.0 million in 2025, then slipped by 5.95% to $192.8 million in 2026.
• Business Quant data shows MYGN's Goodwill & Intangibles at $192.8 million in Q1 2026, $205.0 million in Q4 2025, and $214.7 million in Q3 2025.